PMAD Screening Mandates by State: What OBs Are Required to Do

The Regulatory Landscape

PMAD screening requirements for perinatal providers exist at three levels: federal guideline (USPSTF, ACOG, AAP), state statute, and hospital or system policy. These are not the same, and they do not all apply in the same way.

Federal guidelines: Not legally binding but define the standard of care that courts apply. USPSTF Grade B recommendation and ACOG guidance establish what is expected of a reasonably competent perinatal provider.

State statutes: Legally enforceable requirements that vary significantly by state. Some states mandate screening; others mandate education; others mandate referral pathways; most have nothing beyond federal guidance.

Hospital/system policies: May be more stringent than state law. Providers practicing within a health system may be subject to policies that exceed state requirements.

---

States With PMAD Screening Legislation

New Jersey

New Jersey enacted the first postpartum depression screening statute in 2006 (N.J. Stat. Ann. §§ 26:2-176 to 26:2-179). Key requirements:

• Healthcare professionals who provide postnatal care must provide education about PPD to new mothers and their families
• Screening using a validated tool is required at the first post-delivery visit
• Healthcare professionals must provide information about PPD treatment resources
• Hospitals must provide educational material before discharge

Illinois

Illinois law (Perinatal Mental Health Disorders Prevention and Treatment Act) requires:

• Healthcare providers to screen postpartum patients for perinatal mental health disorders using a validated screening tool
• Referral to appropriate mental health services when screening indicates the need
• Documentation of screening results in the patient's record

California

California law requires:

• Screening for postpartum depression at postpartum visits
• Screening for PPD at pediatric visits (separate statutory provision targeting pediatricians)
• Referral to mental health services when screening is positive

Other states with relevant provisions

Multiple additional states have enacted screening or educational requirements since 2015, including Maryland, Virginia, Massachusetts, Texas, and others. The specific requirements vary: some require universal screening, some require risk assessment and screening, some require only patient education.

This landscape is actively changing. PSI's National Policy Tracker (postpartum.net) is the authoritative current resource for state-by-state legislation. Consult it for current requirements in your state rather than relying on secondary sources.

---

What "Required to Screen" Means in Practice

Where state law mandates screening, the minimum compliance elements typically include:

1. Using a validated instrument. Most statutes specify a validated screening tool without mandating a specific one. The EPDS is the most widely used; the PHQ-9 is also validated for this population. Using an informal clinical assessment is not equivalent to administering a validated tool.
2. At specified timepoints. Where timing is specified (most commonly first postpartum visit, or at specific gestational windows), screening must occur at those times.
3. With documented results. Screening performed but not documented is not auditable compliance.
4. With a follow-up pathway. Most mandates include some form of referral or treatment pathway requirement when screening is positive. The specific requirements vary by state.

---

Hospital Discharge Requirements

Several states have hospital discharge provisions that are distinct from provider-level screening requirements.

New Jersey's statute, for example, requires hospitals to:

• Provide educational materials about PPD before discharge
• Offer to screen patients before discharge
• Provide information about PPD treatment resources

California has similar hospital discharge education requirements. These provisions apply to hospital administrators and nursing staff, not only to treating physicians.

For providers practicing in hospital settings, the discharge process should include the applicable state-mandated components. Compliance is typically tracked at the hospital administrative level, but the attending provider shares responsibility for the patient's care.

---

Medicaid Billing and Reimbursement

Medicaid reimbursement for PMAD screening has expanded as screening mandates have grown. The specific billing codes and reimbursement levels vary by state Medicaid program.

For the federal Medicaid population, the extension of postpartum Medicaid coverage in states that accepted the American Rescue Plan Act extension (to 12 months postpartum) increases the covered window for PMAD screening and treatment in the Medicaid population.

For billing guidance applicable to your practice setting, see our article on billing for behavioral health screening in OB and peds visits.

---

Where Most Providers Fall Short

The gap between the mandate/guideline and actual practice is well-documented. Common shortfalls:

Screening is performed but not documented. Verbal assessments are not equivalent to validated tool administration with scored documentation.

Screening is performed once but not at key timepoints. ACOG recommends screening at least once; some guidelines recommend prenatal and postpartum. Screening only at the 6-week postpartum visit misses women who develop symptoms in weeks 6 to 12.

Positive screens receive no documented follow-up. The most common liability gap: the screening identifies a positive result and the chart shows no response.

Education is provided but referral pathways do not exist. Telling a patient "you should talk to someone" without a specific referral resource is not a compliant response to a positive screen in states that require referral pathways.

Pediatricians who are required to screen are not screening. AAP guidance and several state statutes apply to pediatric well visits. Many pediatric practices have not implemented systematic screening workflows.

---

Building Compliance Into Practice Workflow

Systematic compliance is achieved by building screening into the workflow rather than relying on individual clinician recall:

• Pre-visit screening: Include EPDS in the intake documentation for relevant visit types (new OB, prenatal, postpartum). The patient completes it before the visit; the score is available at the time of clinical interaction.
• EHR-triggered reminders: Configure visit type workflows to prompt for screening at mandated timepoints.
• Standing order protocols: A standing order for PMAD screening at specified visit types removes the decision from the individual encounter and ensures systematic documentation.
• Referral pathways pre-established: Have a designated referral resource (or list) so that follow-up on positive screens does not require ad hoc problem-solving.

---